Kovack Advisors’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $887K | Buy |
10,279
+495
| +5% | +$47.4K | 0.05% | 402 |
|
|
2025
Q4 | $940K | Buy |
9,784
+3,496
| +56% | +$340K | 0.04% | 400 |
|
|
2025
Q3 | $599K | Sell |
6,288
-142
| -2% | -$13.1K | 0.06% | 288 |
|
|
2025
Q2 | $561K | Sell |
6,430
-1,853
| -22% | -$157K | 0.05% | 301 |
|
|
2025
Q1 | $744K | Sell |
8,283
-267
| -3% | -$23.9K | 0.08% | 221 |
|
|
2024
Q4 | $683K | Buy |
8,550
+741
| +9% | +$64.1K | 0.07% | 242 |
|
|
2024
Q3 | $703K | Sell |
7,809
-532
| -6% | -$44.8K | 0.07% | 231 |
|
|
2024
Q2 | $657K | Sell |
8,341
-502
| -6% | -$41.2K | 0.07% | 246 |
|
|
2024
Q1 | $771K | Buy |
8,843
+1,870
| +27% | +$160K | 0.09% | 180 |
|
|
2023
Q4 | $574K | Buy |
6,973
+1,453
| +26% | +$111K | 0.07% | 273 |
|
|
2023
Q3 | $433K | Sell |
5,520
-2,177
| -28% | -$182K | 0.06% | 292 |
|
|
2023
Q2 | $678K | Buy |
7,697
+276
| +4% | +$23.8K | 0.09% | 222 |
|
|
2023
Q1 | $598K | Buy |
7,421
+751
| +11% | +$61.2K | 0.08% | 254 |
|
|
2022
Q4 | $518K | Buy |
6,670
+600
| +10% | +$48.6K | 0.08% | 274 |
|
|
2022
Q3 | $490K | Sell |
6,070
-101
| -2% | -$9.08K | 0.07% | 284 |
|
|
2022
Q2 | $554K | Buy |
6,171
+97
| +2% | +$9.83K | 0.07% | 290 |
|
|
2022
Q1 | $673K | Sell |
6,074
-12
| -0.2% | -$1.27K | 0.07% | 310 |
|
|
2021
Q4 | $630K | Sell |
6,086
-959
| -14% | -$111K | 0.06% | 339 |
|
|
2021
Q3 | $883K | Sell |
7,045
-21
| -0.3% | -$2.72K | 0.1% | 242 |
|
|
2021
Q2 | $877K | Sell |
7,066
-312
| -4% | -$39.2K | 0.1% | 223 |
|
|
2021
Q1 | $872K | Sell |
7,378
-875
| -11% | -$103K | 0.11% | 200 |
|
|
2020
Q4 | $967K | Sell |
8,253
-988
| -11% | -$109K | 0.14% | 162 |
|
|
2020
Q3 | $960K | Sell |
9,241
-517
| -5% | -$51.9K | 0.17% | 143 |
|
|
2020
Q2 | $895K | Sell |
9,758
-1,573
| -14% | -$151K | 0.17% | 142 |
|
|
2020
Q1 | $1.02M | Buy |
11,331
+1,121
| +11% | +$119K | 0.24% | 103 |
|
|
2019
Q4 | $1.16M | Buy |
10,210
+190
| +2% | +$20.8K | 0.21% | 121 |
|
|
2019
Q3 | $1.09M | Buy |
10,020
+3,723
| +59% | +$388K | 0.22% | 116 |
|
|
2019
Q2 | $613K | Buy |
6,297
+588
| +10% | +$53.7K | 0.14% | 178 |
|
|
2019
Q1 | $520K | Buy |
5,709
+512
| +10% | +$45.8K | 0.13% | 192 |
|
|
2018
Q4 | $473K | Buy |
5,197
+1,694
| +48% | +$158K | 0.14% | 177 |
|
|
2018
Q3 | $345K | Buy |
3,503
+678
| +24% | +$62.7K | 0.09% | 267 |
|
|
2018
Q2 | $242K | Sell |
2,825
-702
| -20% | -$58.6K | 0.07% | 332 |
|
|
2018
Q1 | $283K | Buy |
3,527
+114
| +3% | +$9.4K | 0.07% | 333 |
|
|
2017
Q4 | $276K | Buy |
+3,413
| New | +$273K | 0.07% | 322 |
|
|
2017
Q3 | – | Sell |
-3,043
| Closed | -$270K | – | 402 |
|
|
2017
Q2 | $270K | Buy |
+3,043
| New | +$257K | 0.09% | 272 |
|
Other funds holding MDT
VCM
VPM
Kovack Advisors's MDT Position: Q1 2026 in Review
Kovack Advisors increased its Medtronic (MDT) stake by 5.1% in Q1 2026, buying an estimated $47.4K and bringing the position to 10,279 shares worth $887K. The position accounts for 0.05% of the portfolio, ranked #402.
Kovack Advisors first reported a position in MDT in Q2 2017 and has held it in 35 quarters since. The position peaked at $1.16M in Q4 2019. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Kovack Advisors held 10,279 shares of Medtronic worth $887K as of Q1 2026.
- Kovack Advisors bought 495 Medtronic shares in Q1 2026, an estimated $47.4K.
- Medtronic made up 0.05% of Kovack Advisors's portfolio in Q1 2026, its #402 holding.
- Kovack Advisors first reported a position in Medtronic in Q2 2017 and has held it in 35 quarters since.
- Kovack Advisors's Medtronic position peaked at $1.16M in Q4 2019.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Kovack Advisors's 13F filing for Q1 2026, filed 13 May 2026.